Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

Instituto Europeo di Oncologia, Milan

Hospital Universitario Reina Sofía, Córdoba

Hospital Universitario Central de Asturias, Oviedo

Hospital Universitario Virgen del Rocío, Seville

Fundación Instituto Valenciano de Oncología (IVO), Valencia

Hospital Universitario de Basurto, Bilbao

Hospital Lozano Blesa, Zaragoza

Centre Paul Strauss, Strasbourg

Onkologická klinika Fakultní nemocnice Olomouc, Olomouc

General University Hospital in Prague, Prague

Hopital Tenon, Paris

Hospital Europeo Georges Pompidou AP-HP, Paris

Institut Curie, Paris

Institut Universitaire du Cancer Toulouse, Toulouse, Toulouse

Klinikum Dessau (MVZ) - Frauenheilkunde, Dessau

Istituti Ospitalieri Cremona, Cremona

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano., Milan

Ospedale San Gerardo, Monza

Hospital San Joan de Reus, Reus

Institut Català d' Oncologia L'Hospitalet (ICO), Barcelona

Institut Oncologic Baselga-Hospital Quiron Salud Barcelona, Barcelona

Hospital Provincial de Castellón, Castellon

Hospital San Pedro Alcántara, Cáceres

ICO Girona, Girona

Hospital Universitario Juan Ramón Jiménez, Huelva

Hospital Universitario La Paz, Madrid

CHUS Complejo Hospitalario Universitario de Santiago, Santiago de Compostela

Hospital Arnau de Vilanova de Valencia, Valencia

Hospital Universitario Miguel Servet, Zaragoza

Royal United Hospitals Bath NHS Foundation Trust, Bath

Barts Cancer Institute, London

Nottingham University Hospitals NHS Trust, Nottingham

Royal Cornwall Hospital NHS Trust, Truro

Hospital Del Mar, Barcelona

Hospital Universitary Vall D´Hebron, Barcelona

Abertawe Bro Morgannwg University Local Health Board, Singleton Hospital, Swansea